Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TickTracker is a digital health company focused on the prevention and tracking of tick-borne illnesses through community-sourced data. The company's primary product is a mobile application that allows users to report tick sightings and bites in real-time, providing a live map of tick activity to help others avoid high-risk areas. By aggregating this data, TickTracker serves as an educational and public health tool to combat the spread of Lyme disease and other tick-related infections. The platform features a 'Tick Map' that visualizes hotspots and provides users with information on how to identify different tick species and seek medical advice. Founded by Olivia Goodreau, the company works closely with the LivLyme Foundation to support research and advocacy for patients. The app is available globally and aims to reduce the incidence of tick-borne diseases through increased awareness and data sharing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TickTracker.